Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gsk Plc (GSK.LN)

Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 61,400,315
  • Shares Outstanding, K 4,077,829
  • Annual Sales, $ 31,376 M
  • Annual Income, $ 2,575 M
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 1.99
  • Price/Cash Flow 9.54
  • Price/Book 4.49
  • Price/Earnings ttm 24.26
  • Earnings Per Share ttm 0.62
  • Most Recent Earnings $0.10 on 02/05/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.61 (4.24%)
  • Most Recent Dividend 0.160 on 02/20/25
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1,440.740 +4.74%
on 02/24/25
1,560.500 -3.30%
on 03/10/25
+80.000 (+5.60%)
since 02/21/25
3-Month
1,289.000 +17.07%
on 01/14/25
1,560.500 -3.30%
on 03/10/25
+200.500 (+15.32%)
since 12/20/24
52-Week
1,282.500 +17.66%
on 11/15/24
1,823.500 -17.25%
on 05/16/24
-164.800 (-9.85%)
since 03/21/24

Most Recent Stories

More News
Nasdaq Futures Plunge as Alphabet and AMD Earnings Disappoint, U.S. ADP Jobs Report in Focus

March Nasdaq 100 E-Mini futures (NQH25) are trending down -0.91% this morning as disappointing results from Alphabet and Advanced Micro Devices weighed on sentiment.

GOOGL : 163.99 (+0.73%)
MAT : 19.80 (-1.15%)
AAPL : 218.27 (+1.95%)
SMCI : 42.15 (+7.80%)
F : 10.00 (-0.10%)
EL : 66.95 (-1.57%)
MRK : 93.11 (-1.71%)
GSK.LN : 1,509.000 (-0.13%)
DIS : 99.46 (+0.61%)
NOVOB.C.DX : 531.600 (-2.00%)
TSLA : 248.71 (+5.27%)
BNC.LN : 537.000 (+0.94%)
Nasdaq Futures Climb on Upbeat Alphabet Results, U.S. GDP Data and More Big Tech Earnings on Tap

December Nasdaq 100 E-Mini futures (NQZ24) are trending up +0.28% this morning as strong quarterly results from Alphabet boosted sentiment, while investors also awaited a fresh batch of U.S. economic data...

PYPL : 70.19 (+0.75%)
KLAC : 706.49 (-1.39%)
GOOGL : 163.99 (+0.73%)
META : 596.25 (+1.75%)
AVGO : 191.66 (+0.59%)
RDDT : 115.70 (+6.39%)
F : 10.00 (-0.10%)
NQZ24 : 20,947.98s (-0.78%)
ABBV : 210.01 (-0.92%)
SNAP : 9.33 (+1.08%)
DASH : 190.62 (-1.20%)
GSK.LN : 1,509.000 (-0.13%)
Stocks Muted Before the Open With U.S. Inflation Data in Focus

December S&P 500 E-Mini futures (ESZ24) are down -0.15%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.23% this morning as investors refrained from making any big bets ahead of a key U.S....

PYPL : 70.19 (+0.75%)
GOOGL : 163.99 (+0.73%)
CVS : 67.05 (-2.32%)
TXG : 10.39 (+4.42%)
JPM : 241.63 (+1.10%)
NQZ24 : 20,947.98s (-0.78%)
NKE : 67.94 (-5.46%)
GSK.LN : 1,509.000 (-0.13%)
PFE : 26.28 (+0.34%)
NCLH : 20.40 (+1.54%)
WFC : 72.52 (unch)
ALTM : 5.84 (unch)
Stocks Set to Open Higher as Rate Cut Bets Firm, U.S. Jobs Data in Focus

June S&P 500 E-Mini futures (ESM24) are up +0.25%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.37% this morning as speculation over interest rate cuts by major central banks heightened appetite...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
CZR : 27.36 (-3.15%)
ZS : 205.20 (+0.81%)
GPS : 24.55 (+4.38%)
MDB : 192.54 (+1.71%)
CRWD : 362.24 (-1.84%)
GTLB : 50.95 (-0.41%)
HPE : 16.05 (-0.31%)
BBWI : 30.28 (+0.60%)
LULU : 322.62 (-0.56%)
DLTR : 66.75 (+3.34%)
Moderna Investors Just Got Some Bullish News

This news could be worth billions...

GSK.LN : 1,509.000 (-0.13%)
PFE : 26.28 (+0.34%)
MRNA : 32.66 (+0.65%)
Is This a Setback for Moderna?

Moderna's shares slipped after the company announced the delay.

PFE : 26.28 (+0.34%)
GSK.LN : 1,509.000 (-0.13%)
MRNA : 32.66 (+0.65%)
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic

AZN.LN : 11,608.000 (-1.69%)
AZN : 74.93 (-2.08%)
GSK.LN : 1,509.000 (-0.13%)
GSK : 39.24 (-0.43%)
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

These companies are close to launching new products that could supercharge revenue.

LLY : 837.57 (-0.59%)
PFE : 26.28 (+0.34%)
GSK.LN : 1,509.000 (-0.13%)
MRNA : 32.66 (+0.65%)
VRTX : 503.20 (-1.37%)
Babies should get recently approved drug for RSV, CDC says

U.S. health officials are recommending that babies get a recently approved drug to protect them against a respiratory virus

PFE : 26.28 (+0.34%)
GSK.LN : 1,509.000 (-0.13%)
GSK : 39.24 (-0.43%)
AZN.LN : 11,608.000 (-1.69%)
AZN : 74.93 (-2.08%)
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health

/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...

BLU : 14.74 (unch)
GSK.LN : 1,509.000 (-0.13%)
GSK : 39.24 (-0.43%)
BLU.TO : 19.48 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 1,549.167
2nd Resistance Point 1,539.333
1st Resistance Point 1,524.167
Last Price 1,509.000
1st Support Level 1,499.167
2nd Support Level 1,489.333
3rd Support Level 1,474.167

See More

52-Week High 1,823.500
Fibonacci 61.8% 1,616.838
Fibonacci 50% 1,553.000
Last Price 1,509.000
Fibonacci 38.2% 1,489.162
52-Week Low 1,282.500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar